1. In transition to the next generation reference materials and reference measurement procedures for apolipoprotein standardization. (August 2021) Authors: Cobbaert, C.; Begcevic-Brkovic, I.; Dittrich, J.; Kuklenyik, Z.; Ceglarek, U.; Althaus, H.; Angles-Cano, E.; Coassin, S.; Delatour, V.; Deprez, L.; Dikaios, I.; Hoofnagle, A.; Kostner, G.; Kronenberg, F.; Prinzing, U.; Vesper, H.; Ruhaak, R. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SKI-II, a sphingosine kinase 1 inhibitor, exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet. Issue 1 (July 2015) Authors: Potì, F.; Ceglarek, U.; Burkhardt, R.; Simoni, M.; Nofer, J.R. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SKI-II, a sphingosine kinase 1 inhibitor, exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet. Issue 1 (July 2015) Authors: Potì, F.; Ceglarek, U.; Burkhardt, R.; Simoni, M.; Nofer, J.R. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Towards an SI-traceable reference measurement system for serum apolipoproteins (A), A-I, B, C-I, C-II, C-III and E. (August 2022) Authors: Ruhaak, R.; Romijn, F.; Begcevic-Brkovic, I.; Kuklenyik, Z.; Dittrich, J.; Ceglarek, U.; Hoofnagle, A.; Althaus, H.; Angles-Cano, E.; Coassin, S.; Delatour, V.; Deprez, L.; Dikaios, I.; Kostner, G.; Kronenberg, F.; Lyle, A.N.; Prinzing, U.; Vesper, H.W.; Cobbaert, C. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Towards Global Standardization Of Serum/Plasma Apolipoproteins. (August 2019) Authors: Ruhaak, R.; Dittrich, J.; Ceglarek, U.; Delatour, V.; Kostner, G.; Cobbaert, C.; on behalf of IFCC WG APO-MS, Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Towards SI-traceability of lipoprotein (a) measurements: Comparison of a candidate LC-MRM-MS RMP method with commercially available immunoassays for evaluating commutability of candidate reference materials. (August 2022) Authors: Dikaios, I.; Deprez, L.; Althaus, H.; Angles-Cano, E.; Brkovic, I.B.; Boesche, T.; Ceglarek, U.; Coassin, S.; Delatour, V.; Dieplinger, B.; Dittrich, J.; Hoofnagle, A.; Kostner, G.; Kronenberg, F.; Kuklenyik, Z.; Lyle, A.N.; Prinzing, U.; Scharnagl, H.; Vesper, H.W.; Ruhaak, R. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗